Back to Search Start Over

In vivo mesenchymal stem cell tracking with PET using the dopamine type 2 receptor and 18F-fallypride.

Authors :
Schönitzer V
Haasters F
Käsbauer S
Ulrich V
Mille E
Gildehaus FJ
Carlsen J
Pape M
Beck R
Delker A
Böning G
Mutschler W
Böcker W
Schieker M
Bartenstein P
Source :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2014 Aug; Vol. 55 (8), pp. 1342-7. Date of Electronic Publication: 2014 Jul 14.
Publication Year :
2014

Abstract

Unlabelled: Human mesenchymal stem cells (hMSCs) represent a promising treatment approach for tissue repair and regeneration. However, little is known about the underlying mechanisms and the fate of the transplanted cells. The objective of the presented work was to determine the feasibility of PET imaging and in vivo monitoring after transplantation of dopamine type 2 receptor-expressing cells.<br />Methods: An hMSC line constitutively expressing a mutant of the dopamine type 2 receptor (D2R80A) was generated by lentiviral gene transfer. D2R80A messenger RNA expression was confirmed by reverse transcriptase-polymerase chain reaction. Localization of the transmembrane protein was analyzed by confocal fluorescence microscopy. The stem cell character of transduced hMSCs was investigated by adipogenic and osteogenic differentiation. Migration capacity was assessed by scratch assays in time-lapse imaging. In vitro specific binding of ligands was tested by fluorescence-activated cell sorting analysis and by radioligand assay using (18)F-fallypride. Imaging of D2R80A overexpressing hMSC transplanted into athymic rats was performed by PET using (18)F-fallypride.<br />Results: hMSCs showed long-term overexpression of D2R80A. As expected, the fluorescence signal suggested the primary localization of the protein in the membrane of the transduced cells. hMSC and D2R80A retained their stem cell character demonstrated by their osteogenic and adipogenic differentiation capacity and their proliferation and migration behavior. For in vitro hMSCs, at least 90% expressed the D2R80A transgene and hMSC-D2R80A showed specific binding of (18)F-fallypride. In vivo, a specific signal was detected at the transplantation site up to 7 d by PET.<br />Conclusion: The mutant of the dopamine type 2 receptor (D2R80A) is a potent reporter to detect hMSCs by PET in vivo.<br /> (© 2014 by the Society of Nuclear Medicine and Molecular Imaging, Inc.)

Details

Language :
English
ISSN :
1535-5667
Volume :
55
Issue :
8
Database :
MEDLINE
Journal :
Journal of nuclear medicine : official publication, Society of Nuclear Medicine
Publication Type :
Academic Journal
Accession number :
25024426
Full Text :
https://doi.org/10.2967/jnumed.113.134775